We are live on ! Find out more
Two Sigma Investments

Two Sigma Investments Portfolio holdings

AUM $124B
1-Year Est. Return 33.93%
This Fund
S&P 500
This Quarter Est. Return
+8.63%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$31.9B
AUM Growth
+$2.42B
Cap. Flow
+$75.7M
Cap. Flow %
0.24%
Top 10 Hldgs %
7.9%
Holding
3,245
New
801
Increased
908
Reduced
911
Closed
472

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$272M
2
PYPL icon
PayPal
PYPL
+$237M
3
TSLA icon
Tesla
TSLA
+$223M
4
AMD icon
Advanced Micro Devices
AMD
+$169M
5
COR icon
Cencora
COR
+$165M

Sector Composition

Rank Sector Weight
1 Technology 16.55%
2 Healthcare 16.06%
3 Financials 11.25%
4 Industrials 10.24%
5 Consumer Discretionary 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SOBR icon
2676
SOBR Safe
SOBR
$1.67M
$15.6K ﹤0.01%
+15
New +$31.6K
NA
2677
Nano Labs
NA
$43.2M
$15.5K ﹤0.01%
1,345
-165
-11% -$2K
EQ icon
2678
Equillium
EQ
$133M
$15.3K ﹤0.01%
+14,464
New +$23.2K
RGS icon
2679
Regis Corp
RGS
$70.2M
$15.2K ﹤0.01%
623
-136
-18% -$3.23K
AREC icon
2680
American Resources Corp
AREC
$293M
$14.8K ﹤0.01%
11,211
-9,152
-45% -$16.7K
WWR icon
2681
Westwater Resources
WWR
$97.5M
$14.7K ﹤0.01%
18,666
-69,268
-79% -$73.6K
NTBL
2682
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$14.5K ﹤0.01%
3,446
-8,725
-72% -$41K
TOPS icon
2683
TOP Ships
TOPS
$4.24M
$14.1K ﹤0.01%
+926
New +$38K
HPCO
2684
DELISTED
Hempacco Co., Inc. Common Stock
HPCO
$14K ﹤0.01%
+1,709
New +$28.6K
PLX icon
2685
Protalix BioTherapeutics
PLX
$198M
$13.9K ﹤0.01%
10,126
-225
-2% -$247
BTTX
2686
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$13.5K ﹤0.01%
12,192
-6,682
-35% -$9.86K
ALLG.WS
2687
DELISTED
Allego N.V. Warrants
ALLG.WS
$13.3K ﹤0.01%
+133,500
New +$33.7K
HCTI icon
2688
Healthcare Triangle
HCTI
$2.53M
0
RNAZ icon
2689
TransCode Therapeutics
RNAZ
$4.19M
0
INZY
2690
DELISTED
Inozyme Pharma
INZY
$13K ﹤0.01%
12,383
-800
-6% -$1.4K
GSUN icon
2691
Golden Sun Technology Group
GSUN
$4.72M
$12.8K ﹤0.01%
+1,164
New +$122K
ADIL
2692
Adial Pharmaceuticals
ADIL
$8.71M
$12.6K ﹤0.01%
93
VERO
2693
DELISTED
Venus Concept
VERO
$12.5K ﹤0.01%
+236
New +$10.6K
PEAR
2694
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$12.2K ﹤0.01%
+10,347
New +$21.8K
CLNN icon
2695
Clene
CLNN
$67.5M
$12K ﹤0.01%
599
-1,071
-64% -$24.9K
HGEN
2696
DELISTED
HUMANIGEN, INC.
HGEN
$11.9K ﹤0.01%
99,570
+79,369
+393% +$11.5K
CDAK
2697
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$11.7K ﹤0.01%
+29,453
New +$19.4K
VINC
2698
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$11.2K ﹤0.01%
547
-2,187
-80% -$41.2K
LIDR icon
2699
AEye
LIDR
$61.1M
$11.1K ﹤0.01%
770
-1,676
-69% -$43.5K
AEMD icon
2700
Aethlon Medical
AEMD
$1.66M
$11K ﹤0.01%
10
-4
-29% -$7.29K

Similar funds

Two Sigma Investments's Q4 2022 Portfolio in Review

As of Q4 2022, Two Sigma Investments held 3,245 positions worth $31.9B, up 8.2% from $29.4B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Two Sigma Investments's Q4 2022 filing shows 801 new, 908 increased, 911 reduced and 472 closed positions. Its largest new stake was Yum! Brands: 1,187,068 shares worth $152M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $293M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Two Sigma Investments's largest Q4 2022 buy was Yum! Brands: 1,187,068 shares worth $152M.
  • Two Sigma Investments added most to Amazon in Q4 2022, an estimated $272M increase.
  • Two Sigma Investments's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $293M.
  • Two Sigma Investments fully exited JPMorgan Chase in Q4 2022, selling an estimated $226M.
  • Two Sigma Investments's ten largest holdings make up 7.9% of its $31.9B portfolio in Q4 2022.
  • Two Sigma Investments opened 801 new positions and closed 472 in Q4 2022.
  • Two Sigma Investments's portfolio value rose 8.2% quarter-over-quarter to $31.9B.

Based on Two Sigma Investments's 13F filing for Q4 2022, filed 14 Feb 2023.